Karyopharm Therapeutics Inc
NASDAQ:KPTI

Watchlist Manager
Karyopharm Therapeutics Inc Logo
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Watchlist
Price: 6.31 USD -5.26%
Market Cap: 107.6m USD

Profitability Summary

Karyopharm Therapeutics Inc's profitability score is 39/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

39/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

39/100
Profitability
Score
39/100
Profitability
Score

Margins

Earnings Waterfall
Karyopharm Therapeutics Inc

Margins Comparison
Karyopharm Therapeutics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Karyopharm Therapeutics Inc
NASDAQ:KPTI
107.6m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
372.8B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
175.5B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
153.8B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
76.2B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.6B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
40.8B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Karyopharm Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Karyopharm Therapeutics Inc
NASDAQ:KPTI
107.6m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
372.8B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
175.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
153.8B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
76.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.6B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
40.8B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Karyopharm Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate